Scleroderma News

Patients with systemic sclerosis who demonstrate digital ulcers use “significantly more” health care resources annually than patients without digital ulcers, according to data published in Arthritis Care and Research.

Interstitial lung disease and pulmonary arterial hypertension associated with scleroderma often require consultations and co-management with physicians outside of rheumatology.

Patients with systemic autoimmune rheumatic disorders who show evidence of illness-related uncertainty also tend to experience depression, anxiety and increased sickness impact, according to data published in the Journal of Rheumatology.

The FDA has cleared two tests from Thermo Fisher Scientific to help diagnose systemic sclerosis and systemic lupus erythematosus, according to a company press release.

Specialized physical therapy may prevent deterioration and improve sexual function in female patients with systemic sclerosis and idiopathic inflammatory myopathies, according to data presented at the EULAR 2022 Congress.

SAN FRANCISCO — New real-world data demonstrate treatment with selexipag improved outcomes in patients with pulmonary arterial hypertension associated with connective tissue disease.

DESTIN, Fla. — Genetic and environmental factors, as well as autoantibodies, “likely play a role” in the expression of systemic sclerosis, according to Zsuzsanna McMahan, MD, MHS, of Johns Hopkins University School of Medicine.

Myositis Awareness Month is focused on raising awareness and amplifying voices for patients with diseases falling under the myositis umbrella.

Rheumatologists are likely to be at the “forefront” of diagnosing scleroderma skin disorders and other dermatological conditions, a speaker said at Congress of Clinical Rheumatology East.

DESTIN, Fla. — Stepwise interventions, starting with diet and moving on to pharmacotherapies in more severe patients, is essential to managing gastrointestinal complications in scleroderma, a speaker said at the Congress of Clinical Rheumatology East.